@doconco.bsky.social Welche Wege gibt es dazu? Das kann ja echt nicht sein. Gibt es dafür schon fertige Begründungen, richterl. Entscheidungen, Studien, die man beilegen kann? #Atezolizumab (Handelsname #Tecentriq)
Müsste doch eigentlich wirklich passen? 🙏 www.fachinfo.de/fi/pdf/021700

Paper out in Biomedicine & Pharmacotherapy! 🔬🧑‍🔬👩🏼‍🔬
“Light-enhanced cytotoxicity & trafficking of the PD-L1-targeting photoimmunoconjugate EITC-atezolizumab” 👉 lnkd.in/dz-zF-Hx Novel: #Atezolizumab clusters w/ #CD63 pos #MVBs
#Photoimmunotherapy #lungcancer
#PDL1 #Tecentriq #NSCLC #PhotodynamicTherapy

Genprex Begins Acclaim-3 Phase 2 Trial for Gene Therapy in Lung Cancer Patients Genprex has initiated the Phase 2 expansion for the Acclaim-3 study, focusing on Reqorsa gene therapy combined with Tecentriq to treat extensive stage small cell lung cancer.

Genprex Begins Acclaim-3 Phase 2 Trial for Gene Therapy in Lung Cancer Patients #United_States #Austin #Genprex #Reqorsa #Tecentriq

Genprex Advances to Phase 2 in Acclaim-3 Clinical Trial Evaluating Gene Therapy for Lung Cancer Genprex, Inc. has gained approval to proceed to Phase 2 of the Acclaim-3 clinical trial for Reqorsa® gene therapy combined with Tecentriq® for extensive-stage small cell lung cancer.

Genprex Advances to Phase 2 in Acclaim-3 Clinical Trial Evaluating Gene Therapy for Lung Cancer #USA #Austin #Genprex #Reqorsa #Tecentriq

Interesting summary of #morpheusliver #HCC data and issues. #tigit inh. #tiragolumab + #tecentriq #avastin performed well vs. #IMBRAVE150 doublet but latter underperformed. PFS unprecedented. Exciting but await #IMBRAVE152 to confirm #livertwitter...

Reflecting on #IMBRAVE050 adjuvant data for #tecentriq #avastin in #HCC I suspect a major impact in Asia where resection w curative intent is a dominant strategy & hope that our surgical volumes will rise in North America as we identify those likely to benefit #livertwitter

While we were sleeping stateside, the #IMBRAVE050 white smoke arose from Basel. #tecentriq #avastin adjuvant rx improves RFS in high recurrence risk #HCC
Survival data “immature” and details sparse but first proven adjuvant rx would be game changer. ...

Looking at K-M survival curves for #tecentriq #avastin vs. #nexavar, curves separate at 6 mos but more importantly looks like 60% still alive beyond 17 mos. The promise of IO profound durable responses in #HCC for many may be finally within sight $RHHBY

@AASLDtweets dr. Llovet: beta catenin activation may promote resistance to #HCC IO therapies like #opdivo #keytruda and #tecentriq more data needed to confirm this #LiverMtg2019

@AASLDtweets clearly the era of combo systemic Rx for #HCC has been ushered with #tecentriq + #avastin , #keytruda + #lenvima and now #Opdivo +#yervoy looming at the horizon. I definitely foresee an HCC centric #livermtg20 #LiverMtg19